Series B funding round for Allorion Therapeutics raising $50M in March 2023
Series B funding round for Allorion Therapeutics raising $50M in March 2023
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
INCE CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Accelerator | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Sue Xu |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$90M
Top Valuation
-
Allorion Therapeutics raised $50M in a Series B round.
The round was announced on 03/01/23.
The round was led by INCE Capital, Chen Kan.